This has probably been posted before, but another look is good for the soul...
Here is the source:
https://ashpublications.org/blood/article/142/Supplement%201/7013/501154/Efficacy-of-Treatment-Options-for-Children-with
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L, page-157
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.23 |
Change
-0.080(6.13%) |
Mkt cap ! $1.364B | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.30 | $1.17 | $10.27M | 8.332M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 57009 | $1.22 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.23 | 55099 | 16 |
View Market Depth
| Last trade - 11.12am 24/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |